On Friday,
October 31st, AbbVie Inc. (ABBV) announced
that its Board of Directors approved a quarterly dividend increase
from $1.64 to $1.73 per share. The dividend is payable on February
17, 2026, to shareholders of record as of January 16, 2026. This
marks a 5.49% increase over the previous quarterly dividend.
At the current price of $211.96 (yesterday’s close), this increase will raise ABBV’s dividend yield
to 3.26%.
AbbVie is a Dividend Contenders with a
13 year streak of dividend increases. Dividend growth rates for 1, 3,
5 and 10 years are 4.7, 6.0, 7.7 and 14.1 (Dividend
Champions.xls)
As an owner of 80 shares of ABBV, the
recent dividend increase adds $21.46 to my projected annual net
dividend income.
I was expecting a dividend increase of
around 5%, so this announcement aligns perfectly with my
expectations. It’s always nice to see AbbVie continue its strong
track record of rewarding shareholders with consistent dividend
growth.
This marks the eleventh dividend
increase I’ve received from AbbVie since initiating my position in
October 2016. Over that time, the company’s quarterly dividend has
grown impressively from $0.57 to $1.73 per share — a cumulative
increase of 203.5%. AbbVie continues to demonstrate its commitment to
delivering strong and reliable income growth for shareholders.
As of this writing, AbbVie represents
approximately 2.0% of my portfolio by weight and contributes around
1.53% to my projected annual dividend income.
Following this increase, my yield on
cost is 10.09%.
Summary of 2025 Dividend Increases /
Cuts
Click here
to see my portfolio holdings.
You can follow the development of my
dividends here.
Full Disclosure: Long ABBV
Thanks for stopping by!